ReviewInfection and immunity1992
Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.
Review in Infection and immunity, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi.Infection and immunity · 2001Article
- Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis.Infection and immunity · 2001Article
- Structure and sequence analysis of Yersinia YadA and Moraxella UspAs reveal a novel class of adhesins.The EMBO journal · 2000Article
- The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.Infection and immunity · 1998Article
- Phase-variable expression of lipopolysaccharide contributes to the virulence of legionella pneumophila.The Journal of experimental medicine · 1998Article
- Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope.Proceedings of the National Academy of Sciences of the United States of America · 1998Article
- Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.Infection and immunity · 1997Article
- Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis.Infection and immunity · 1994Article
- The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA.Immunology · 1994Article
- Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteria.Infection and immunity · 1993Article
- Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells.Infection and immunity · 1993Article
- Aeromonas salmonicida grown in vivo.Infection and immunity · 1993Article
- Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules.Infection and immunity · 1993Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.